Predictors of response to antiviral treatment for chronic hepatitis B

J Chin Med Assoc. 2017 Jun;80(6):329-330. doi: 10.1016/j.jcma.2017.03.005. Epub 2017 Apr 29.

Authors

Yi-Hsiang Huang¹, Shou-Dong Lee²

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC; Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC. Electronic address: yhhuang@vghtpe.gov.tw.
² Cheng Hsin General Hospital, Taipei, Taiwan, ROC.

PMID: 28465108
DOI: 10.1016/j.jcma.2017.03.005

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use*
Hepatitis B e Antigens / blood
Hepatitis B, Chronic / drug therapy*
Hepatitis B, Chronic / virology
Humans
Viral Load

Substances

Antiviral Agents
Hepatitis B e Antigens